After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023 at 15:40 PM EDT
Roivant shares gain more than 10% after narrower-than-expected quarterly loss.
Photography by Christophe Tomatis